BioLargo's Product Wins Cat Fancy Magazine Editor's Choice Award

SANTA ANA, CA--(Marketwired - Oct 30, 2013) - BioLargo, Inc. (OTCQB: BLGO) today announced that Cat Fancy Magazine awarded its Litter Deodorizing Concentrate an "Editor's Choice Award," naming it one of the 18 "Best Products of the Year" for 2013. Detailed in the December issue on newsstands now, the Cat Fancy editor commented, "I have four cats in a small house. After I started using this, I noticed an immediate reduction in odor and moisture. I'm not going through nearly as much litter, and I like the fact that it's environmentally friendly and non-toxic."

In August of this year the product also won an Editor's Choice Award from Pet Product News International, the leading industry trade publication. Their tester stated, "At first I was highly skeptical of its odor control, but after a couple days, I was amazed that I hadn't smelled the cat's urine or poop at all... even when the cat didn't cover the urine, there was no smell coming from the litter box."

"We are proud the industry recognizes the value of our cat litter product," stated BioLargo President Dennis Calvert. "We hope to soon introduce a $1.00 per week introductory offer to target the 48 million households in the USA that love cats and want the best product on the market to help keep their litter box and home odor-free."

The product is available through BioLargo's wholly owned subsidiary Odor-No-More, Inc., at NaturesBestSolution.com, or ask for it wherever you buy pet products.

About BioLargo, Inc.

We make life better by delivering technology-based products that help solve some of the world's most important problems that threaten our water, food, agriculture, healthcare and energy. Our website is www.BioLargo.com. Our subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, and consumer markets, including the Nature's Best Solution® and Deodorall® brands. (www.OdorNoMore.com). Our subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com), focuses on advanced wound care management and is preparing to make FDA 510(k) applications in early 2014. Our subsidiary BioLargo Water, Inc. (www.BioLargoWater.com), showcases our "advanced oxidation systems," including its AOS filter, a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminates in water in a fraction of the time of current technologies. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project.

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K for the year ended December 31, 2012.

Contact Information:

Dennis P. Calvert
President
949-643-9540